SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001104659-24-098640
Filing Date
2024-09-10
Accepted
2024-09-10 17:03:04
Documents
12

Document Format Files

Seq Description Document Type Size
1 FORM S-1 tm2423565d1_s1.htm S-1 369442
2 EXHIBIT 1.4 tm2423565d1_ex1-4.htm EX-1.4 46143
3 EXHIBIT 4.3 tm2423565d1_ex4-3.htm EX-4.3 90584
4 EXHIBIT 4.4 tm2423565d1_ex4-4.htm EX-4.4 87621
5 EXHIBIT 5.1(A) tm2423565d1_ex5-1a.htm EX-5.1(A) 14369
6 EXHIBIT 5.1(B) tm2423565d1_ex5-1b.htm EX-5.1(B) 13989
7 EXHIBIT 10.34 tm2423565d1_ex10-34.htm EX-10.34 209070
8 EXHIBIT 23.1 tm2423565d1_ex23-1.htm EX-23.1 2365
9 EX-FILING FEES tm2423565d1_ex-filingfees.htm EX-FILING FEES 19058
10 GRAPHIC tm2423565d1_s1img001.jpg GRAPHIC 9731
11 GRAPHIC tm2423565d1_s1img002.jpg GRAPHIC 136096
12 GRAPHIC tm2423565d1_ex5-1bimg001.jpg GRAPHIC 2298
  Complete submission text file 0001104659-24-098640.txt   1058478
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Theriva Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

IRS No.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-282024 | Film No.: 241290733
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)